Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089582019 | Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5089583012 | Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Is a | Product containing only betamethasone and salicylic acid in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | Conventional release cutaneous lotion | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has precise active ingredient | Betamethasone dipropionate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has basis of strength substance | Betamethasone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has precise active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has basis of strength substance | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and salicylic acid 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR